152 related articles for article (PubMed ID: 15986108)
1. Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.
Dumeaux V; Fournier A; Lund E; Clavel-Chapelon F
Cancer Causes Control; 2005 Jun; 16(5):537-44. PubMed ID: 15986108
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
3. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
[TBL] [Abstract][Full Text] [Related]
4. Use of oral contraceptives, alcohol, and risk for invasive breast cancer.
Dumeaux V; Lund E; Hjartåker A
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1302-7. PubMed ID: 15298950
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
[TBL] [Abstract][Full Text] [Related]
6. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
7. Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study.
Kawai M; Minami Y; Kuriyama S; Kakizaki M; Kakugawa Y; Nishino Y; Ishida T; Fukao A; Tsuji I; Ohuchi N
Cancer Causes Control; 2010 Jan; 21(1):135-45. PubMed ID: 19816778
[TBL] [Abstract][Full Text] [Related]
8. [Estrogen and natural products in the treatment of postmenopausal complaints. Oral contraceptives prepare the way for hormonal substitution].
Hammar M; Frisk J; Brynhildsen J; Dabrosin L; Lindgren R; Nedstrand E; Wyon Y
Lakartidningen; 1997 Mar; 94(12):1084-8. PubMed ID: 9121242
[TBL] [Abstract][Full Text] [Related]
9. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
10. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
11. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
[TBL] [Abstract][Full Text] [Related]
12. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
13. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
14. Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis.
Lumachi F; Frigo AC; Basso U; Tombolan V; Ermani M
Menopause; 2010; 17(3):524-8. PubMed ID: 20130492
[TBL] [Abstract][Full Text] [Related]
15. [Estrogen replacement therapy and breast cancer].
Bakken K; Alsaker E; Eggen AE; Lund E
Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study.
Espié M; Mares P; de Reilhac P; Chevallier T; Daurès JP
Gynecol Endocrinol; 2006 Aug; 22(8):423-31. PubMed ID: 17012103
[TBL] [Abstract][Full Text] [Related]
17. Body shape throughout life and the risk for breast cancer at adulthood in the French E3N cohort.
Fagherazzi G; Guillas G; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
Eur J Cancer Prev; 2013 Jan; 22(1):29-37. PubMed ID: 22694827
[TBL] [Abstract][Full Text] [Related]
18. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
[TBL] [Abstract][Full Text] [Related]
19. A population-based cohort study of HRT use and breast cancer in southern Sweden.
Olsson H; Bladström A; Ingvar C; Möller TR
Br J Cancer; 2001 Sep; 85(5):674-7. PubMed ID: 11531250
[TBL] [Abstract][Full Text] [Related]
20. 20. Oral contraceptives, hormone replacement therapy and breast cancer.
Fentiman IS
Int J Clin Pract; 2002 Dec; 56(10):755-9. PubMed ID: 12510949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
